V8 Peptides — Engineered Performance
Research Library
Tesamorelin Quality Standards for Research Labs
TesamorelinQuality & Testing

Tesamorelin Quality Standards for Research Labs

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

How should a laboratory evaluate the quality of research-grade tesamorelin? Read the HPLC purity as a resolved-peak figure under one method, ask for identity data and a lot-specific certificate where published, and check the features specific to this 44-residue analog: the N-terminal hexenoyl group, Met27 oxidation and asparagine deamidation. Verify mass, keep chromatograms, and re-test aged stock. Stock arithmetic is on the reconstitution calculator; certificates are in the COA library where published.

Evaluating a research peptide is more than reading a percentage. For a long, modified peptide such as tesamorelin, the percentage hides three things worth knowing: what the method can miss, which impurities are likely, and what you can verify yourself. This guide lays those out and ends with the questions that make documentation useful. The material is supplied for laboratory research use only; not for human consumption.

What the product page specifies

The tesamorelin product page describes a hexenoyl-modified GHRH analog supplied as lyophilized powder in a 10 mg sealed clear glass vial. The molecular formula given is C221H366N72O67S, the sequence begins with a trans-3-hexenoyl group on the N-terminal tyrosine, and purity is stated as ≥98% by HPLC. Where a lot-specific certificate of analysis has been published, the COA library lists it by lot. Storage is stated as refrigerate at 2–8 °C, −20 °C for long-term, and protect from heat, moisture and light.

Those lines are the starting point for a quality evaluation, not the end of it. A purity figure is a single number from a single method, and a laboratory that depends on the material should know what the number means, what it leaves out and what it can add itself. This guide goes through that reasoning for a 44-residue modified peptide. It does not cover the basics of reading a certificate, which are in how to read a COA, nor the existing overview in tesamorelin purity testing. The material is supplied for laboratory research use only; not for human consumption.

What a purity percentage means

A reversed-phase HPLC purity figure is normally the area of the main peak expressed as a share of all peaks detected at one wavelength under one gradient. That has four consequences. Impurities that do not absorb at the detection wavelength are not counted. Impurities that co-elute with the main peak are counted as the main peak. Impurities that elute in the solvent front or are retained on the column are missed. And peptide content, the share of the powder weight that is peptide rather than water, counter-ion or residual salt, is a different quantity entirely. The principles are covered in understanding HPLC purity.

For a 44-residue peptide the limit of the method matters more than for a short one. Synthesis by the solid-phase route builds the chain one residue at a time, and each coupling step has a small failure rate, so a long chain has more opportunities for deletion and insertion impurities (D'Hondt and colleagues, 2014). A ≥98% specification is therefore a statement about resolved, UV-detectable impurities under the stated method, and not a statement about every molecule in the vial.

Impurity classes relevant to a long modified peptide

ClassOriginDetected byRelevance to tesamorelin
Deletion peptidesInefficient deprotection during synthesisHPLC peaks near the main peak; mass spectrometryMore opportunities in a 44-residue chain
Insertion peptidesExcess activated residueHPLC; mass spectrometryPossible at any position
N-terminal acyl variantsIncomplete or double acylation of the N-terminusMass shift of the acyl group; HPLCThe hexenoyl group is the defining feature of this analog
Methionine sulfoxideOxidation of Met27 during synthesis, storage or handlingEarlier-eluting peak, +16 DaThe sequence on the page contains one methionine, at position 27
Deamidated formsAsn or Gln side-chain hydrolysisShifted retention, +1 DaThe sequence has Asn residues; Asn8 deamidation produced the major degradants of a related GRF analog
AggregatesConcentrated solution, agitation, freeze–thawSize-exclusion chromatography, light scatteringLong peptides can self-associate
Residual counter-ions and waterCleavage and lyophilizationPeptide content analysisAffects weighing and molar concentration, not UV purity

Peptide-related impurities of this kind are well catalogued for synthetic peptides, and the same review notes that they can influence early functional studies and lead to erroneous conclusions (D'Hondt and colleagues, 2014). That is the practical reason to care: an uncharacterized impurity is a hidden variable in an assay.

The tesamorelin-specific features to check

The N-terminal group. The defining modification is a trans-3-hexenoic acid group attached to Tyr1. It makes the peptide resistant to deactivation by dipeptidyl peptidase IV, and in plasma from rat, dog and human it slowed in vitro degradation relative to natural GHRH(1-44)-NH2 (Ferdinandi and colleagues, 2007). An acyl cap adds about 96 mass units (C6H8O) to the unmodified peptide, so a mass measurement that finds the unmodified mass instead is the clearest sign that the cap is missing. This is arithmetic from the chemical formula of the group, not a published specification.

The methionine. The sequence contains Met27. Methionine is among the residues most susceptible to oxidation, and oxidation is promoted by contaminating oxidants, transition metal ions and light (Li and colleagues, 1995). Sulfoxide forms typically elute slightly earlier on reversed-phase columns and add 16 mass units, so they are easy to look for.

The asparagines. Deamidation of Asn8 produced the major degradation products of a related GRF analog at pH 7.4 and 37 °C (Friedman and colleagues, 1991), and the sequence on the product page carries Asn at position 8, the residue that deamidated in that study. Deamidation adds only one mass unit and is hard to see; the usual signs are small shoulders on the main peak.

What a laboratory can ask for and verify

CheckWhat it showsWho normally does itWhat to record
Lot-specific HPLC trace and purity valueResolved UV-detectable purity for that lot, under stated conditionsProducer or independent analyst; listed in the COA library where publishedLot, date, method conditions, main-peak area
Identity by massObserved molecular mass against the expected valueMass spectrometry; where the certificate states itObserved mass, expected mass, difference
Sequence confirmationResidue order, including the N-terminal groupTandem mass spectrometry or amino acid analysisMethod and coverage
Peptide contentShare of powder weight that is peptideAmino acid analysis or nitrogen contentValue used for weighing
Appearance on receiptPhysical state of the cakeThe receiving researcherDescription, vial integrity, storage on arrival
In-house HPLC of a fresh stockWhether the laboratory's system reproduces the traceThe receiving researcher with an available instrumentChromatogram, retention time, area
Re-test of an aged stockWhether the stock has changedThe receiving researcherTime zero vs time n peak areas

Only the items that appear on a certificate can be assumed. If a document states a purity value but no identity method, that is what it states; the difference between HPLC and mass spectrometry, and why the latter answers a different question, is in HPLC vs mass spectrometry. Why independent analysis adds weight is covered in third-party testing explained.

Handling choices that protect quality after receipt

The most common loss of quality happens after the vial arrives. Let a cold vial reach room temperature before opening. The product page notes that larger peptides can take a little longer to dissolve, so allow a few minutes before judging clarity, add diluent slowly against the glass, swirl and do not shake. Stock concentration is vial mass divided by diluent volume; the reconstitution calculator does the arithmetic. Portion the stock into single-use tubes, record thaw counts and keep oxidants and transition metals away from it. Storage tiers and the evidence limits on solution stability are set out in tesamorelin reconstitution and storage.

Documents and questions for any supplier

  • Is the certificate lot-specific, and does the lot on the document match the lot on the vial?
  • Does it state the HPLC method conditions, such as column, gradient and detection wavelength, or only the purity value?
  • Does it state an identity method and an observed mass?
  • Is the test date shown, and was the analysis done on the material in the vial or on a reference batch?
  • Is peptide content stated, or only chromatographic purity?
  • What is the stated storage and what was the condition on arrival?
  • Is there a way to ask for the raw chromatogram?

A general framework for these questions is in vetting a research peptide supplier and red flags when buying research peptides. For sourcing context specific to this compound, see where to buy tesamorelin.

What published work does and does not establish

The literature on tesamorelin describes its development as a stabilized analog of human growth hormone-releasing factor (Wang and Tomlinson, 2009), its non-clinical pharmacology and safety (Ferdinandi and colleagues, 2007) and, as a class, the instability of GRF analogs (Friedman and colleagues, 1991). It does not provide analytical acceptance criteria for research-grade lyophilized material, and no impurity limit should be attributed to it. The standards a laboratory applies are its own: a purity floor, an identity requirement, a re-test rule and a documentation rule, written down before the first vial arrives. The compound-level background is in the tesamorelin research overview.

All material discussed is supplied for laboratory research use only; not for human consumption.

Related reading

Frequently asked questions

What does ≥98% HPLC purity mean?

It is the main-peak area as a share of all detected peaks under one method and wavelength. It does not count impurities that are invisible or co-eluting, and it is not the same as peptide content.

Why does a 44-residue peptide need extra scrutiny?

Solid-phase synthesis adds residues one at a time, and each step has a small failure rate, so long chains have more opportunities for deletion and insertion impurities.

What is the hexenoyl group on tesamorelin?

A trans-3-hexenoic acid group on the N-terminal tyrosine. It confers resistance to dipeptidyl peptidase IV and slowed in vitro degradation in plasma compared with natural GHRH(1-44)-NH2.

How would a missing hexenoyl group show up?

As a mass lower by about 96 units than expected. That is arithmetic from the group's formula and is checked by mass spectrometry.

Why is methionine oxidation relevant?

The sequence contains Met27. Methionine is highly oxidation-prone, and oxidation is promoted by oxidants, metal ions and light. Sulfoxide forms add 16 mass units.

Is deamidation visible on a chromatogram?

Only weakly. It adds one mass unit and usually appears as a small shoulder or shifted peak, so high-resolution methods are needed to confirm it.

What does peptide content measure?

The share of the powder weight that is peptide as opposed to water, counter-ions and salts. It affects weighing accuracy and molar concentration.

Can I assume a certificate includes mass spectrometry?

No. Only what the certificate states can be assumed. Check whether it lists an identity method and an observed mass.

How do I check an aged stock?

Run an HPLC trace at time zero, keep it, and re-run the same method on a fresh portion at later points, comparing the main peak area and any new peaks.

Where is the lot certificate?

The product page links a lot-specific certificate where one is published, and the COA library lists certificates by lot.

Related reading: Tesamorelin History: From GHRH Discovery to Analog, Tesamorelin Preclinical Studies: GH Response and Stability.

References

  1. D'Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. doi:10.1016/j.jpba.2014.06.012
  2. Ferdinandi ES, Brazeau P, High K, Procter B, Fennell S, Dubreuil P. Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue. Basic Clin Pharmacol Toxicol. 2007;100(1):49-58. doi:10.1111/j.1742-7843.2007.00008.x
  3. Wang Y, Tomlinson B. Tesamorelin, a human growth hormone releasing factor analogue. Expert Opin Investig Drugs. 2009;18(3):303-310. doi:10.1517/13543780802707658
  4. Li S, Schöneich C, Borchardt RT. Chemical instability of protein pharmaceuticals: mechanisms of oxidation and strategies for stabilization. Biotechnol Bioeng. 1995;48(5):490-500. doi:10.1002/bit.260480511
  5. Friedman AR, Ichhpurani AK, Brown DM, et al. Degradation of growth hormone releasing factor analogs in neutral aqueous solution is related to deamidation of asparagine residues. Int J Pept Protein Res. 1991;37(1):14-20. doi:10.1111/j.1399-3011.1991.tb00727.x

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.